Advance Drug Safety with Virscio’s Pharmacology and Pharmacodynamic Research
Expertise in Safety Pharmacology for Confident Therapeutic Development
Virscio is your trusted partner for safety pharmacology and pharmacodynamic research, from preclinical proof-of-concept to IND-enabling studies. We are a translational research organization with over 20 years of preclinical experience, dedicated to therapeutic innovation and R&D efficiency. Our platform combines collaborative engagement, unparalleled primate access, and scientific expertise to efficiently generate definitive data, reducing therapeutic development risks in various medical fields.
In this overview, we highlight how our world-class Pharmacology and Pharmacodynamic research platform provides comprehensive services from initial study design to execution and reporting. With scientific and technical expertise spanning disease modeling, pharmacodynamics, pharmacokinetics, and toxicology, Virscio offers established protocols for evaluating a wide range of therapeutics.
Discover how Virscio’s Safety Pharmacology Services can bring clarity and confidence to your R&D investment decisions, enhancing the likelihood of clinical success.
Explore Our Safety Pharmacology Services Now!
Discover how Virscio’s Safety Pharmacology Services can bring clarity and confidence to your R&D investment decisions, enhancing the likelihood of clinical success.
Virscio is dedicated to de-risking innovation and ensuring accurate characterization of human risk and response to therapeutic candidates. Our unparalleled access to biologically clean primates enables timely study initiation, guided by specific research objectives.
In this overview of our Cardiovascular Safety Pharmacology and Pharmacodynamic capabilities, you will learn about:
- Noninvasive cardiac physiology assessments including ECG, blood pressure, heart rate, and respiratory rate measurements.
- Advanced echocardiography techniques and cardiovascular access and dosing methodologies.
- Cardiovascular diseases modeling, including renal artery stenosis induced hypertension and transverse artery constriction (TAC) induced congestive failure.
- Quantitative and analytical methods for characterizing response to intervention, using telemetry and echocardiography.
Connect with Our Experts: Schedule a Consultation Today!
